ALLIANCEBERNSTEIN L.P. - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$73,413
-61.3%
68,610
-6.4%
0.00%
Q2 2023$189,821
-25.9%
73,290
+16.7%
0.00%
Q1 2023$256,224
-14.2%
62,800
+5.5%
0.00%
Q4 2022$298,690
-40.9%
59,500
+54.1%
0.00%
Q3 2022$505,000
+2.0%
38,6000.0%0.00%
Q2 2022$495,000
+17.3%
38,600
+39.4%
0.00%
Q1 2022$422,000
-19.5%
27,700
-6.4%
0.00%
Q4 2021$524,000
-65.2%
29,600
-58.6%
0.00%
-100.0%
Q3 2021$1,505,000
+110.2%
71,576
+97.2%
0.00%
Q2 2021$716,000
-0.3%
36,300
+47.0%
0.00%
Q1 2021$718,000
-20.5%
24,700
-17.1%
0.00%
Q4 2020$903,000
+82.1%
29,800
-4.5%
0.00%
Q3 2020$496,000
-22.7%
31,200
-4.0%
0.00%
Q2 2020$642,000
+95.1%
32,500
+21.7%
0.00%
Q1 2020$329,000
+21.0%
26,700
+81.6%
0.00%
Q4 2019$272,000
+50.3%
14,700
+12.2%
0.00%
Q3 2019$181,00013,1000.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$59,928,00049.90%
Greenspring Associates, LLC 1,573,357$25,032,00038.95%
Svennilson Peter 18,017,932$286,665,00023.39%
Aquilo Capital Management, LLC 1,018,334$16,202,0001.72%
Jasper Ridge Partners, L.P. 308,750$4,912,0000.28%
Samsara BioCapital, LLC 36,451$580,0000.16%
Rock Springs Capital Management LP 360,454$5,735,0000.15%
Point72 Asset Management, L.P. 1,611,850$25,645,0000.13%
Virtus ETF Advisers LLC 14,880$237,0000.12%
WELD CAPITAL MANAGEMENT LLC 15,238$242,0000.10%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders